| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/21/2011 | US20110091481 Biomarkers for predicting response to immunosuppressive therapy |
| 04/21/2011 | US20110091480 Antigen-Binding Proteins Targeting S. Aureus Orf0657n |
| 04/21/2011 | US20110091479 Novel anti-igf-ir antibodies and uses thereof |
| 04/21/2011 | US20110091478 Methods of using antibodies against human il-22 |
| 04/21/2011 | US20110091477 Modulators of hepatocyte growth factor activator |
| 04/21/2011 | US20110091476 Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors |
| 04/21/2011 | US20110091475 Anti-Human Interleukin-20 Antibodies |
| 04/21/2011 | US20110091474 Compositions and Methods For Diagnosing and Treating Diabetic Micro Vascular Complications |
| 04/21/2011 | US20110091473 Novel antibody therapies |
| 04/21/2011 | US20110091472 Compositions for treating psoriasis |
| 04/21/2011 | US20110091471 Treatment method for epithelial cancerous organism |
| 04/21/2011 | US20110091470 Anti-flt3 antibodies |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091468 Connective tissue growth factor antibodies |
| 04/21/2011 | US20110091467 Compositions and methods for modulating dopamine neurotransmission |
| 04/21/2011 | US20110091466 IgE ANTIBODIES FOR THE TREATMENT OF CANCER |
| 04/21/2011 | US20110091465 Polypeptides |
| 04/21/2011 | US20110091464 Novel peptides and protein and uses thereof |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091462 Novel antigen binding dimer-complexes, methods of making and uses thereof |
| 04/21/2011 | US20110091461 Binding domain-immunoglobulin fusion proteins |
| 04/21/2011 | US20110091460 Receptor-targeting reagents |
| 04/21/2011 | US20110091459 Imidazole modulators of muscarinic acetylcholine receptor m3 |
| 04/21/2011 | US20110091458 Anti-il 13 human antibodies |
| 04/21/2011 | US20110091457 Method for prognosticating the clinical response of a patient to b-lymphocyte inhibiting or depleting therapy |
| 04/21/2011 | US20110091456 Treatment of neurological conditions |
| 04/21/2011 | US20110091455 Antibodies to myostatin |
| 04/21/2011 | US20110091454 Methods and systems for annotating biomolecular sequences |
| 04/21/2011 | US20110091453 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory diseases |
| 04/21/2011 | US20110091452 4,5-Dihydromacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies |
| 04/21/2011 | US20110091451 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 04/21/2011 | US20110091450 Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| 04/21/2011 | US20110091449 Isolation of Anti-Desmoglein 1 Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies |
| 04/21/2011 | US20110091448 Methods for regulation of stem cells |
| 04/21/2011 | US20110091447 Lymphocyte control of obesity and insulin resistance |
| 04/21/2011 | US20110091446 Single domain antibodies capable of modulating bace activity |
| 04/21/2011 | US20110091445 Modulation of intestinal flora of hiv patients |
| 04/21/2011 | US20110091444 Methods and compositions for treatment and prevention of major depressive disorder |
| 04/21/2011 | US20110091418 Methods for treating viral infections using polyamine analogs |
| 04/21/2011 | US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders |
| 04/21/2011 | US20110091416 Immunoglobulin fusion proteins |
| 04/21/2011 | US20110091414 Stabilized compositions of proteins having a free thiol moiety |
| 04/21/2011 | US20110091413 Therapeutic use of interleukin-2 mutants |
| 04/21/2011 | US20110091407 Polymer derived from linear polyethylenimine for gene transfer |
| 04/21/2011 | US20110091386 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 04/21/2011 | US20110091384 Biomarker for identification of melanoma tumor cells |
| 04/21/2011 | US20110091380 Chlorotoxins as drug carriers |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | US20110091378 Methods and Compositions for Treating Fibrosis Related Disorders Using IL-17 Antagonists |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | CA2780961A1 Composition for treatment of multiple sclerosis |
| 04/21/2011 | CA2777845A1 Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| 04/21/2011 | CA2777823A1 Antibody therapeutics with local activity in the digestive tract |
| 04/21/2011 | CA2777692A1 Isolation of a virus related to canine parvovirus-2 from a raccoon |
| 04/21/2011 | CA2777400A1 Granulysin in immunotherapy |
| 04/21/2011 | CA2777242A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |
| 04/21/2011 | CA2777226A1 Cancer treatment |
| 04/21/2011 | CA2776712A1 Use of il-17 receptor a antigen binding proteins |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | CA2775402A1 Il-1 binding proteins |
| 04/21/2011 | CA2775277A1 Infectious clones of torque teno virus |
| 04/20/2011 | EP2311991A1 S. pneumoniae antigens |
| 04/20/2011 | EP2311990A1 S. pneumoniae antigens |
| 04/20/2011 | EP2311989A1 S. pneumoniae antigens |
| 04/20/2011 | EP2311988A1 S. pneumoniae antigens |
| 04/20/2011 | EP2311987A1 S. pneumoniae antigens |
| 04/20/2011 | EP2311980A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311979A1 Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer |
| 04/20/2011 | EP2311978A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311958A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/20/2011 | EP2311957A1 Antigens from granulocytic Ehrlichia |
| 04/20/2011 | EP2311955A2 Osteoprotegerin binding proteins and their receptors |
| 04/20/2011 | EP2311954A1 Mutations in the Parkin gene, compositions, methods and uses |
| 04/20/2011 | EP2311953A1 Bone/joint disease susceptibility gene and use thereof |
| 04/20/2011 | EP2311952A2 Antibodies to MRT-1 protein or fragments thereof |
| 04/20/2011 | EP2311951A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311950A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311946A1 Anti-system asc amino acid transporter 2 (asct2) antibody |
| 04/20/2011 | EP2311945A1 Bispecific antibodies substituting for functional proteins |
| 04/20/2011 | EP2311944A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 04/20/2011 | EP2311881A2 Cripto binding molecules |
| 04/20/2011 | EP2311880A2 Cripto binding molecules |
| 04/20/2011 | EP2311879A2 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 04/20/2011 | EP2311878A2 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 04/20/2011 | EP2311877A2 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 04/20/2011 | EP2311876A2 M-CSF-specific monoclonal antibody and uses thereof |
| 04/20/2011 | EP2311875A1 Treatment with anti-VEGF antibodies |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311870A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311869A1 Use of mammalian cytokine; related reagents |
| 04/20/2011 | EP2311868A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311862A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311861A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311860A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311859A1 Uses of a novel Eimeria gene and corresponding protein |
| 04/20/2011 | EP2311853A1 Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| 04/20/2011 | EP2311532A1 Anti-viral griffithsin compounds, compositions, and methods of use |
| 04/20/2011 | EP2311531A1 Anti-viral griffithsin compounds, compositions, and methods of use |
| 04/20/2011 | EP2311495A1 Vascularization inhibitors |
| 04/20/2011 | EP2311493A1 Cytotoxic composition |